Can the UroLift prostatic implant device treat the symptoms of benign prostatic hypertrophy, avoid sexual dysfunction and reduce hospital TURP waiting times? A single centre, single surgeon experience and review of the literature

Abstract

BPH associated with LUTS and sexual dysfunction is common. We performed UroLift on 11 patients, average age 71 years (range 56-90). IPSS improved by an average of 9 points post-procedure. Pre-operatively their post-void residuals were 306.3 ml (range 120-499 ml SD [120.6]) and their Q was 7 ml/s (range 4-14 SD [2.8] ml/s). Post-procedure the post-void residual decreased by 35.4% at 4 months (mean difference - 106.3 ml). Q improved by an average of 1.7 ml/s, which was not statistically significant. No patients suffered any sexual dysfunction side effects and all patients were satisfied with their result. Hospital stay and theatre time were significantly reduced. Average length of stay was just 10.6 (6-18) hours and average theatre time just 18.7 (12-30) min. This is significantly faster than other surgery for LUTS. We therefore feel that there are significant benefits for both the patients, who are able to go home much faster, and also the hospital, who are able to perform far more surgeries for their patients. Patients also do not require an inpatient bed so patients should not be cancelled on the day of theatre.

UroLift for the Treatment of Lower Urinary Tract Symptoms in a Patient with AMS 700 Penile Prosthesis: The First Reported Case

“…There are multiple advantages for use of the UroLift device over TURP surgery for LUTS resulting from BPH. 9 UroLift is considerably less invasive and can be performed under local anesthesia, it has reduced sexual dysfunction, and has shorter operative times. 10 As a result, the UroLift procedure can be performed as a day case procedure, which in turn alleviates bed pressures in NHS trusts.…”

“…10 As a result, the UroLift procedure can be performed as a day case procedure, which in turn alleviates bed pressures in NHS trusts. 9 Outcomes following UroLift are favourable and there have been multiple studies confirming that it is an effective method for managing LUTS due to BPH. Bardolli et al 9 reported 11 cases of UroLift in a single-centre cohort study demonstrating a reduction in IPSS at 4 months post-operatively of −9.1 (mean pre-operative IPSS = 25.4, mean post-operative = 16.3, p = 0.02).…”

“…9 Outcomes following UroLift are favourable and there have been multiple studies confirming that it is an effective method for managing LUTS due to BPH. Bardolli et al 9 reported 11 cases of UroLift in a single-centre cohort study demonstrating a reduction in IPSS at 4 months post-operatively of −9.1 (mean pre-operative IPSS = 25.4, mean post-operative = 16.3, p = 0.02). 9 There was also reduction in PVR volume at 4 months with a pre-operative mean of 300.1 mL to 193.8 mL post-operatively (difference = -106.3 mL, p = 0.04).…”

“…Bardolli et al 9 reported 11 cases of UroLift in a single-centre cohort study demonstrating a reduction in IPSS at 4 months post-operatively of −9.1 (mean pre-operative IPSS = 25.4, mean post-operative = 16.3, p = 0.02). 9 There was also reduction in PVR volume at 4 months with a pre-operative mean of 300.1 mL to 193.8 mL post-operatively (difference = -106.3 mL, p = 0.04). Bardoli et al also reported significant improvement in QoL scores (5.1 vs. 3.5, difference -1.6).…”

Is There a Minimally Invasive Day Case Operation to Treat LUTS Secondary to BPH and Avoid Sexual Dysfunction? UroLift A Case Report

“…Urolift also shows quantitative improvements in urinary flow rates and post-void residual volumes which will have greater long-term benefits on urological health. 3 Recent publication of results from the L.I.F.T IDE Study has concluded that the Urolift system has definitive five-year durability also.…”